These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22830501)

  • 21. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.
    Lin Q; Jin CS; Huang H; Ding L; Zhang Z; Chen J; Zheng G
    Small; 2014 Aug; 10(15):3072-82. PubMed ID: 24706435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
    Lee SJ; Huh MS; Lee SY; Min S; Lee S; Koo H; Chu JU; Lee KE; Jeon H; Choi Y; Choi K; Byun Y; Jeong SY; Park K; Kim K; Kwon IC
    Angew Chem Int Ed Engl; 2012 Jul; 51(29):7203-7. PubMed ID: 22696263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.
    Lee J; Saw PE; Gujrati V; Lee Y; Kim H; Kang S; Choi M; Kim JI; Jon S
    Theranostics; 2016; 6(2):192-203. PubMed ID: 26877778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
    Jin J; Bae KH; Yang H; Lee SJ; Kim H; Kim Y; Joo KM; Seo SW; Park TG; Nam DH
    Bioconjug Chem; 2011 Dec; 22(12):2568-72. PubMed ID: 22070554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.
    Yu YH; Kim E; Park DE; Shim G; Lee S; Kim YB; Kim CW; Oh YK
    Eur J Pharm Biopharm; 2012 Feb; 80(2):268-73. PubMed ID: 22108492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein-Like Nanoparticle Carrying Small Interfering RNA Against Spalt-Like Transcription Factor 4 Effectively Targets Hepatocellular Carcinoma Cells and Decreases Tumor Burden.
    Cruz W; Huang H; Barber B; Pasini E; Ding L; Zheng G; Chen J; Bhat M
    Hepatol Commun; 2020 May; 4(5):769-782. PubMed ID: 32363325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
    Zheng Y; Liu Y; Jin H; Pan S; Qian Y; Huang C; Zeng Y; Luo Q; Zeng M; Zhang Z
    Theranostics; 2013; 3(7):477-86. PubMed ID: 23843895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.
    Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J
    Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
    Shahzad MM; Mangala LS; Han HD; Lu C; Bottsford-Miller J; Nishimura M; Mora EM; Lee JW; Stone RL; Pecot CV; Thanapprapasr D; Roh JW; Gaur P; Nair MP; Park YY; Sabnis N; Deavers MT; Lee JS; Ellis LM; Lopez-Berestein G; McConathy WJ; Prokai L; Lacko AG; Sood AK
    Neoplasia; 2011 Apr; 13(4):309-19. PubMed ID: 21472135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA.
    Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ
    Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo.
    Fu GF; Lin XH; Han QW; Fan YR; Xu YF; Guo D; Xu GX; Hou YY
    Cancer Biol Ther; 2005 Aug; 4(8):822-9. PubMed ID: 16210911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.